Aberrant Subclavian Artery
What is Aberrant Subclavian Artery?
Aberrant Subclavian Artery is an anomaly of the vascular system. It is very rare and often goes unnoticed because of its lack of symptoms. A congenital disease, meaning present from prior to or at birth, Aberrant Subclavian Artery, is usually discovered accident
Moloraeri tem ut faccus, id quissundi nost, cum volecat rae deliat voluptis quam audit re omnis inverru ptatio que dolesto cuscipsam ea qui re landestiunt endam inum fugitaestrum faccabo rporeni aturias sundis que estiae ea por aut ipsus.
What are the symptoms of Aberrant Subclavian Artery?
Common symptoms of Aberrant Subclavian Artery include the following:- In a minority of cases, the anomaly can cause swallowing difficulty
- Children that have swallowing problems my seek medical attention due to feeding difficulties and a history of respiratory infections.
- In cases with children who are symptomatic, health care providers should carefully monitor patient for other cardiac and vascular abnormalities.
What causes Aberrant Subclavian Artery?
ssimi nulparia cusande conse nobitatur sa ex exerectum voloriasim que alistium ipit am ipsum ut perit ipsam faci ditinis nossunt omnis sus, aut modi dolecte omnihillab ipsapero volupta essimusHow is Aberrant Subclavian Artery diagnosed?
Many times Abberrant Subclavian Artery is without symptoms. In these cases, the diagnoses was made accidentally in treating something else.What are the treatments for Aberrant Subclavian Artery?
When aberrant subclavian artery causes no symptoms, treatment is not needed. If the anomaly is causing significant symptoms, treatment may involve surgery.Where can I find out more about Aberrant Subclavian Artery?
Aberrant Subclavian Artery Articles

FDA Grants Full Approval to Rucaparib for BRCA-Mutated mCRPC
Austin Newman
January 7, 2026
Read More »

Deucrictibant Provides Rapid Relief for Hereditary Angioedema Attack Symptoms
Bree Clare
January 7, 2026
Read More »

Incyte Reports Positive Phase III Results for Tafasitamab in First-Line DLBCL Treatment
Austin Newman
January 7, 2026
Read More »

Repurposing Breast Cancer Drug Offers New Hope for Acute Myeloid Leukemia Patients
Bree Clare
January 6, 2026
Read More »

Living with gMG: Lessons from William, a Nurse and Patient
Patient Worthy Contributor
January 6, 2026
Read More »

FDA Approve Drug That Targets Root Cause of Life-Threatening Kidney Disease Affecting Children and Young Adults
Rose Duesterwald
January 6, 2026
Read More »

Tonsillectomy Plus Immunosuppression Improves Outcomes in High-Risk IgA Nephropathy Among Caucasians
Austin Newman
January 5, 2026
Read More »
